KR20070026552A - 카르보라닐포르피린 및 이의 용도 - Google Patents

카르보라닐포르피린 및 이의 용도 Download PDF

Info

Publication number
KR20070026552A
KR20070026552A KR1020067025283A KR20067025283A KR20070026552A KR 20070026552 A KR20070026552 A KR 20070026552A KR 1020067025283 A KR1020067025283 A KR 1020067025283A KR 20067025283 A KR20067025283 A KR 20067025283A KR 20070026552 A KR20070026552 A KR 20070026552A
Authority
KR
South Korea
Prior art keywords
compound
porphyrin
patient
metal ions
boron
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020067025283A
Other languages
English (en)
Korean (ko)
Inventor
하이타오 우
미치코 미우라
Original Assignee
브룩하벤 싸이언스 어쏘씨에이츠
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 브룩하벤 싸이언스 어쏘씨에이츠 filed Critical 브룩하벤 싸이언스 어쏘씨에이츠
Publication of KR20070026552A publication Critical patent/KR20070026552A/ko
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/009—Neutron capture therapy, e.g. using uranium or non-boron material
    • A61K41/0095—Boron neutron capture therapy, i.e. BNCT, e.g. using boronated porphyrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
KR1020067025283A 2004-05-20 2005-05-17 카르보라닐포르피린 및 이의 용도 Ceased KR20070026552A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/848,741 US6995260B2 (en) 2004-05-20 2004-05-20 Carboranylporphyrins and uses thereof
US10/848,741 2004-05-20

Publications (1)

Publication Number Publication Date
KR20070026552A true KR20070026552A (ko) 2007-03-08

Family

ID=35375345

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020067025283A Ceased KR20070026552A (ko) 2004-05-20 2005-05-17 카르보라닐포르피린 및 이의 용도

Country Status (11)

Country Link
US (1) US6995260B2 (enExample)
EP (1) EP1753468A4 (enExample)
JP (1) JP2008505983A (enExample)
KR (1) KR20070026552A (enExample)
CN (1) CN1968705A (enExample)
AU (1) AU2005327597B2 (enExample)
CA (1) CA2567468A1 (enExample)
IL (1) IL179497A0 (enExample)
NO (1) NO20065858L (enExample)
NZ (1) NZ551732A (enExample)
WO (1) WO2006088476A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2397067B (en) * 2002-12-23 2005-05-11 Destiny Pharma Ltd Porphin & azaporphin derivatives with at least one cationic-nitrogen-containing meso-substituent for use in photodynamic therapy & in vitro sterilisation
US20070093463A1 (en) * 2004-05-20 2007-04-26 Brookhaven Science Associates, Llc Radiation enhancement agent for X-ray radiation therapy and boron neutron-capture therapy
GB2415372A (en) 2004-06-23 2005-12-28 Destiny Pharma Ltd Non photodynamical or sonodynamical antimicrobial use of porphyrins and azaporphyrins containing at least one cationic-nitrogen-containing substituent
GB0427589D0 (en) 2004-12-16 2005-01-19 Psimei Pharmaceuticals Plc Process for the preparation of a substituted porphyrin
US8287839B2 (en) * 2006-12-04 2012-10-16 Brookhaven Science Associates, Llc Carboranylporphyrins and uses thereof
WO2008102669A1 (ja) * 2007-02-19 2008-08-28 Rei Medical Co., Ltd. 新規な糖連結クロリン誘導体及びその製造方法
US8444953B2 (en) * 2007-03-22 2013-05-21 Brookhaven Science Associates, Llc Symmetric and asymmetric halogen-containing metallocarboranylporphyrins and uses thereof
US20080279781A1 (en) * 2007-05-10 2008-11-13 Brookhaven Science Associates, Llc Glycosylated Carboranylporphyrins and Uses Thereof
JP5745415B2 (ja) * 2009-09-17 2015-07-08 国立大学法人九州大学 ポルフィリン化合物
WO2011050575A1 (en) * 2009-10-28 2011-05-05 The University Of Hong Kong Hydroxy-substituted gold(iii) porphyrin complexes as histone deacetylase inhibitors
CN102268003B (zh) * 2011-06-16 2013-10-30 扬州大学 不对称多取代卟啉金(iii)类抗癌化合物及其制备方法
GB201221125D0 (en) * 2012-11-23 2013-01-09 Morex Dev Partners Llp Pharmaceutial formulations
KR102885276B1 (ko) * 2021-07-13 2025-11-11 삼성에스디아이 주식회사 염료, 이를 포함하는 조성물, 필름, 광학 부재 및 디스플레이 장치
CN114015066B (zh) * 2021-11-12 2022-08-12 北京大学 共价有机框架材料、其制备方法和用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783529A (en) * 1985-12-03 1988-11-08 Research Corporation Technologies Rapid synthesis of radiolabeled porphyrin complexes for medical application
US5162231A (en) * 1989-10-25 1992-11-10 Cole Dean A Method of using 5,10,15,20-tetrakis(carboxyphenyl)porphine for detecting cancers of the lung
US4959356A (en) * 1989-05-26 1990-09-25 The United States Of America As Represented By The United States Department Of Energy Porphyrins for boron neutron capture therapy
FR2656866B1 (fr) * 1990-01-10 1992-05-15 Cis Bio Int Derives de porphyrine et metalloporphyrines eventuellement couples a une molecule biologiquement active, et composition pharmaceutique les contenant.
US5654423A (en) * 1990-11-21 1997-08-05 Regents Of The University Of California Boronated metalloporphyrine and therapeutic methods
US5149801A (en) * 1990-11-21 1992-09-22 The Regents Of The University Of California Boronated porphyrin compounds
US5312896A (en) * 1992-10-09 1994-05-17 Sri International Metal ion porphyrin-containing poly(imide)
DE4305523A1 (de) * 1993-02-17 1994-08-18 Diagnostikforschung Inst Meso-Tetraphenylporphyrin-Komplexverbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
US5563132A (en) * 1994-06-21 1996-10-08 Bodaness; Richard S. Two-step cancer treatment method
US5648485A (en) * 1994-10-26 1997-07-15 University Of British Columbia β, β-dihydroxy meso-substituted chlorins, isobacteriochlorins, and bacteriochlorins
US5877165A (en) * 1995-11-02 1999-03-02 Brookhaven Science Associates Boronated porhyrins and methods for their use
US5955586A (en) * 1996-03-22 1999-09-21 Sessler; Jonathan L. Highly boronated derivatives of texaphyrins
WO1998030102A1 (en) * 1997-01-09 1998-07-16 Emory University Non-iron metalloporphyrins and methods of use
US6010805A (en) * 1998-05-26 2000-01-04 United States Of America As Represented By The Secretary Of The Air Force Ion conducting electrolyte material containing a lithium porphyrin complex
AU2001274827A1 (en) 2000-05-09 2001-11-20 The Regents Of The University Of California Porphyrin-based neutron capture agents for cancer therapy
US6566517B2 (en) * 2001-06-06 2003-05-20 Brookhaven Science Associates, Llc Metalloporphyrins and their uses as imageable tumor-targeting agents for radiation therapy
US7087214B2 (en) * 2002-02-01 2006-08-08 Zentaris Gmbh Water-soluble porphyrin platinum compounds with high tumor selectivity and their use for the treatment of benign and malignant tumor diseases
GB0222945D0 (en) * 2002-10-03 2002-11-13 Psimei Pharmaceuticals Plc Therapeutic compositions

Also Published As

Publication number Publication date
EP1753468A2 (en) 2007-02-21
WO2006088476A3 (en) 2006-12-21
JP2008505983A (ja) 2008-02-28
NZ551732A (en) 2011-03-31
CN1968705A (zh) 2007-05-23
EP1753468A4 (en) 2010-05-26
US6995260B2 (en) 2006-02-07
NO20065858L (no) 2007-02-09
AU2005327597A1 (en) 2006-08-24
US20050260128A1 (en) 2005-11-24
AU2005327597B2 (en) 2011-02-24
WO2006088476A2 (en) 2006-08-24
IL179497A0 (en) 2011-08-01
CA2567468A1 (en) 2006-08-24

Similar Documents

Publication Publication Date Title
RU2477161C2 (ru) Карборанилпорферины и их применение
WO2008069974A1 (en) Radiation enhancement agents for x-ray radiation therapy and boron neutron-capture therapy
KR20070026552A (ko) 카르보라닐포르피린 및 이의 용도
US20080279781A1 (en) Glycosylated Carboranylporphyrins and Uses Thereof
CN1988848B (zh) 碳硼烷基卟啉及其应用
US8444953B2 (en) Symmetric and asymmetric halogen-containing metallocarboranylporphyrins and uses thereof
HK1109039B (en) Carboranylporphyrins and uses thereof
Wu et al. Carboranylporphyrins and uses thereof
HK1133552B (en) Carboranylporphyrins and uses thereof
HK1107013A (en) Carboranylporphyrins and uses thereof

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20061130

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20100405

Comment text: Request for Examination of Application

PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20111130

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20120531

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20111130

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I